Global status of diabetes prevention and prospects for action: A consensus statement

被引:39
|
作者
Ibrahim, Mahmoud [1 ]
Tuomilehto, Jaakko [2 ,3 ,4 ]
Aschner, Pablo [5 ]
Beseler, Lucille [6 ]
Cahn, Avivit [7 ,8 ]
Eckel, Robert H. [9 ]
Fischl, Amy Hess [10 ]
Guthrie, George [11 ]
Hill, James O. [12 ]
Kumwenda, Mick [13 ]
Leslie, R. David [14 ]
Olson, Darin E. [15 ]
Pozzilli, Paolo [16 ,17 ]
Weber, Sandra L. [18 ]
Umpierrez, Guillermo E. [19 ]
机构
[1] EDC Ctr Diabet Educ, McDonough, GA 30253 USA
[2] Dasman Diabet Inst, Kuwait, Kuwait
[3] Natl Inst Hlth & Welf, Chron Dis Prevent Unit, Helsinki, Finland
[4] King Abdulaziz Univ, Diabet Res Grp, Jeddah, Saudi Arabia
[5] Javeriana Univ, San Ignacio Univ Hosp, Sch Med, Bogota, Colombia
[6] Family Nutr Ctr South Florida, Coconut Creek, FL USA
[7] Hadassah Hebrew Univ Hosp, Diabet Unit, Jerusalem, Israel
[8] Hadassah Hebrew Univ Hosp, Endocrinol & Metab Unit, Jerusalem, Israel
[9] Univ Colorado Denver, Univ Colorado Hosp, Anschutz Med Campus, Denver, CO USA
[10] Univ Chicago, Kovler Diabet Ctr, Chicago, IL 60637 USA
[11] Florida Hosp Grad Med Educ, Orlando, FL USA
[12] Univ Colorado, Sch Med, Colorado Nutr Obes Res Ctr NORC, Aurora, CO USA
[13] Glan Clwyd Gen Hosp, Rhyl, Wales
[14] Queen Mary Univ London, Blizard Inst, London, England
[15] Emory Univ, Sch Med, Div Endocrinol Metab & Lipids, Atlanta, GA USA
[16] Univ Campus Biomed, Unit Endocrinol & Diabet, Rome, Italy
[17] Queen Mary Univ London, Ctr Immunobiol, Barts & London Sch Med, London, England
[18] Univ South Carolina, Greenville Hlth Syst, Sch Med Greenville, Greenville, SC USA
[19] Emory Univ, Sch Med, Atlanta, GA USA
关键词
diabetes prevention; prediabetes; obesity; MEDICAL NUTRITION THERAPY; LIFE-STYLE INTERVENTION; BODY-MASS INDEX; PRACTICE GUIDELINE; HIGH-RISK; AMERICAN ASSOCIATION; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; WEIGHT-LOSS; HEALTH;
D O I
10.1002/dmrr.3021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Primary prevention of type 2 diabetes (T2D) should be achievable through the implementation of early and sustainable measures. Several randomized control studies that found success in preventing the progression to T2D in high-risk populations have identified early and intensive intervention based on an individualized prevention model as the key factor for participant benefit. The global prevalence of both overweight and obesity has now been widely recognized as the major epidemic of the 21st century. Obesity is a major risk factor for the progression from normal glucose tolerance to prediabetes and then to T2D. However, not all obese individuals will develop prediabetes or progress to diabetes. Intensive, multicomponent behavioural interventions for overweight and obese adults can lead to weight loss. Diabetes medications, including metformin, GLP-1 agonists, glitazones, and acarbose, can be considered for selected high-risk patients with prediabetes when lifestyle-based programmes are proven unsuccessful. Nutrition education is the cornerstone of a healthy lifestyle. Also, physical activity is an integral part of the prediabetes management plan and one of the main pillars in the prevention of diabetes. Mobile phones, used extensively worldwide, can facilitate communication between health professionals and the general population, and have been shown to be helpful in the prevention of T2D. Universal screening is needed. Noninvasive risk scores should be used in all countries, but they should be locally validated in all ethnic populations focusing on cultural differences around the world. Lifestyle interventions reduce the progression to prediabetes and diabetes. Nevertheless, many questions still need to be answered.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Call to action for clinicians in the South-East Asian regions on primary prevention of diabetes in people with prediabetes- A consensus statement
    Ramachandran, Ambady
    Nanditha, Arun
    Tuomilehto, Jaakko
    Gabriel, Rafael
    Saboo, Banshi
    Mohan, Viswanathan
    Chawla, Manoj
    Chawla, Purvi
    Raghavan, Arun
    Gupta, Amit
    Joshi, Shashank
    Agarwal, Sanjay
    Misra, Anoop
    Sahay, Rakesh
    Tiwaskar, Mangesh H.
    Khan, A. K. Azad
    Arvind, S. R.
    Viswanathan, Vijay
    Das, Ashok Kumar
    Makkar, Brij Mohan
    Kowlessur, Sudhirsen
    Yajnik, Chittaranjan S.
    Sriram, Usha
    Seshadri, Krishna G.
    Susairaj, Priscilla
    Satheesh, Krishnamoorthy
    Duncan, Bruce B.
    Aschner, Pablo
    Barengo, Noel
    Schwarz, Peter E. H.
    Ceriello, Antonio
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2025, 221
  • [2] Prevention and Management of Noncommunicable Disease: The IOC Consensus Statement, Lausanne 2013
    Matheson, Gordon O.
    Kluegl, Martin
    Engebretsen, Lars
    Bendiksen, Fredrik
    Blair, Steven N.
    Boerjesson, Mats
    Budgett, Richard
    Derman, Wayne
    Erdener, Ugur
    Ioannidis, John P. A.
    Khan, Karim M.
    Martinez, Rodrigo
    van Mechelen, Willem
    Mountjoy, Margo
    Sallis, Robert E.
    Schwellnus, Martin
    Shultz, Rebecca
    Soligard, Torbjorn
    Steffen, Kathrin
    Sundberg, Carl Johan
    Weiler, Richard
    Ljungqvist, Arne
    CLINICAL JOURNAL OF SPORT MEDICINE, 2013, 23 (06): : 419 - 429
  • [3] Consensus on the Prevention of Type 2 Diabetes in Chinese Adults
    Tong, Yu-Zhen
    Tong, Nan-Wei
    Teng, Wei-Ping
    Mu, Yi-Ming
    Zhao, Jia-Jun
    Shan, Zhong-Yan
    Ning, Guang
    CHINESE MEDICAL JOURNAL, 2017, 130 (05) : 600 - 606
  • [4] Revised Global Consensus Statement on Menopausal Hormone Therapy
    de Villiers, T. J.
    Hall, J. E.
    Pinkerton, J. V.
    Cerdas Perez, S.
    Rees, M.
    Yang, C.
    Pierroz, D. D.
    CLIMACTERIC, 2016, 19 (04) : 313 - 315
  • [5] Global consensus statement on menopausal hormone therapy - an update
    Fenton, Anna
    Panay, Nick
    CLIMACTERIC, 2016, 19 (04) : 311 - 312
  • [6] Exercise management in type 1 diabetes: a consensus statement
    Riddell, Michael C.
    Gallen, Ian W.
    Smart, Carmel E.
    Taplin, Craig E.
    Adolfsson, Peter
    Lumb, Alistair N.
    Kowalski, Aaron
    Rabasa-Lhoret, Remi
    McCrimmon, Rory J.
    Hume, Carin
    Annan, Francesca
    Fournier, Paul A.
    Graham, Claudia
    Bode, Bruce
    Galassetti, Pietro
    Jones, Timothy W.
    Millan, Inigo San
    Heise, Tim
    Peters, Anne L.
    Petz, Andreas
    Laffel, Lori M.
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (05): : 377 - 390
  • [7] DIABETES AND CANCER-AN AACE/ACE CONSENSUS STATEMENT
    Handelsman, Yehuda
    LeRoith, Derek
    Bloomgarden, Zachary T.
    Dagogo-Jack, Samuel
    Einhorn, Daniel
    Garber, Alan J.
    Grunberger, George
    Harrell, R. Mack
    Gagel, Robert F.
    Lebovitz, Harold E.
    McGill, Janet B.
    Hennekens, Charles H.
    ENDOCRINE PRACTICE, 2013, 19 (04) : 675 - 693
  • [8] Prevention and Management of Non-Communicable Disease: The IOC Consensus Statement, Lausanne 2013
    Matheson, Gordon O.
    Kluegl, Martin
    Engebretsen, Lars
    Bendiksen, Fredrik
    Blair, Steven N.
    Borjesson, Mats
    Budgett, Richard
    Derman, Wayne
    Erdener, Ugur
    Ioannidis, John P. A.
    Khan, Karim M.
    Martinez, Rodrigo
    van Mechelen, Willem
    Mountjoy, Margo
    Sallis, Robert E.
    Schwellnus, Martin
    Shultz, Rebecca
    Soligard, Torbjorn
    Steffen, Kathrin
    Sundberg, Carl Johan
    Weiler, Richard
    Ljungqvist, Arne
    SPORTS MEDICINE, 2013, 43 (11) : 1075 - 1088
  • [9] Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action
    Grams J.
    Garvey W.T.
    Current Obesity Reports, 2015, 4 (2) : 287 - 302
  • [10] Physical Activity, Insulin Action, and Diabetes Prevention and Control
    Colberg, Sheri R.
    CURRENT DIABETES REVIEWS, 2007, 3 (03) : 176 - 184